Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) (ASPEN-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03608397
Recruitment Status : Completed
First Posted : August 1, 2018
Last Update Posted : February 1, 2021
Sponsor:
Collaborator:
Syneos Health
Information provided by (Responsible Party):
Revance Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 3, 2019
Actual Study Completion Date : June 16, 2020
Certification/Extension First Submitted : December 22, 2020